Emergent BioSolutions (EBS) Cost of Revenue (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly Cost of Revenue of $72.0 million for Q1 2026, down 18.64% year-over-year from $88.5 million in Q1 2025, and down 15.19% quarter-over-quarter from $84.9 million in Q4 2025.
Emergent BioSolutions (EBS) Cost of Revenue (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Cost of Revenue history runs 16 years deep, the most recent figure standing at $72.0 million for Q1 2026.
- In Q1 2026, Cost of Revenue fell 18.64% year-over-year to $72.0 million; the TTM figure through Mar 2026 stood at $309.7 million (down 18.31% YoY), while the FY2025 annual figure was $326.2 million, down 52.12% from the prior year.
- Cost of Revenue for Q1 2026 stood at $72.0 million, down from $84.9 million in the prior quarter.
- The five-year high for Cost of Revenue was $190.6 million in Q2 2023, with the low at $50.0 million in Q2 2024.
- The 5-year median for Cost of Revenue is $118.0 million (2024), against an average of $118.4 million.
- The sharpest annual moves came in 2022 and 2024: Cost of Revenue jumped 9194.44% in 2022, then sank 73.77% in 2024.
- Emergent BioSolutions' Cost of Revenue stood at $167.3 million in 2022, then increased by 10.64% to $185.1 million in 2023, then slumped by 36.25% to $118.0 million in 2024, then declined by 28.05% to $84.9 million in 2025, then dropped by 15.19% to $72.0 million in 2026.
- Business Quant data shows EBS's Cost of Revenue at $72.0 million in Q1 2026, $84.9 million in Q4 2025, and $85.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | 97.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 97.10 Mn |
| Jun 30, 2026 | 97.10 Mn |
| Mar 31, 2026 | 72.00 Mn |
| Mar 31, 2026 | 72.00 Mn |
| Dec 31, 2025 | 84.90 Mn |
| Dec 31, 2025 | 84.90 Mn |
| Sep 30, 2025 | 85.90 Mn |
| Sep 30, 2025 | 85.90 Mn |
| Jun 30, 2025 | 66.90 Mn |
| Jun 30, 2025 | 66.90 Mn |
| Mar 31, 2025 | 88.50 Mn |
| Mar 31, 2025 | 88.50 Mn |
| Dec 31, 2024 | 118.00 Mn |
| Dec 31, 2024 | 118.00 Mn |
| Sep 30, 2024 | 122.60 Mn |
| Sep 30, 2024 | 122.60 Mn |
| Jun 30, 2024 | 50.00 Mn |
| Jun 30, 2024 | 50.00 Mn |
| Mar 31, 2024 | 144.60 Mn |
| Mar 31, 2024 | 144.60 Mn |